Do patients with psoriatic arthritis who present early fare better than those presenting later in the disease?
- 12 September 2011
- journal article
- research article
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 70 (12), 2152-2154
- https://doi.org/10.1136/ard.2011.150938
Abstract
Background This investigation aimed to determine whether patients presenting to a psoriatic arthritis (PsA) clinic early in the course of the disease had less severe disease at presentation, and whether disease duration at presentation predicts progression of joint damage. Methods Patients followed prospectively in a specialised clinic were divided into those first seen within 2 years of diagnosis (group 1) and those seen with more than 2 years of disease (group 2). The groups were compared with regard to demographics and disease characteristics at presentation. A multivariate analysis using a negative binomial model was conducted to determine whether patients with early disease had less progression of joint damage. Results 436 patients were identified in group 1 and 641 patients in group 2. Patients in group 2 were older, had longer duration of psoriasis and PsA, more joint damage and were less likely to be treated with disease-modifying antirheumatic drugs, but had similar level of education and degree of psoriasis severity. After adjusting for age, sex, education level, clinical joint damage at first visit and treatment, group 2 had significantly greater rate of clinical damage progression compared with group 1. Conclusions Disease progression is more marked in patients presenting with established disease of more than 2 years' duration. These results suggest that patients with PsA should be treated earlier in the course of their disease.Keywords
This publication has 14 references indexed in Scilit:
- Inflammation in an individual joint predicts damage to that joint in psoriatic arthritisAnnals Of The Rheumatic Diseases, 2010
- Observational cohort studies: lessons learnt from the University of Toronto Psoriatic Arthritis ProgramRheumatology, 2010
- Psoriatic Arthritis from Wright's Era Until TodayThe Journal of Rheumatology, 2009
- Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment: Results from the induction and maintenance psoriatic arthritis clinical trial 2Arthritis & Rheumatism, 2007
- Predictors for radiological damage in psoriatic arthritis: results from a single centreAnnals Of The Rheumatic Diseases, 2007
- A longitudinal study of the effect of disease activity and clinical damage on physical function over the course of psoriatic arthritis: Does the effect change over time?Arthritis & Rheumatism, 2007
- Adalimumab for long‐term treatment of psoriatic arthritis: Forty‐eight week data from the adalimumab effectiveness in psoriatic arthritis trialArthritis & Rheumatism, 2007
- Clinical and radiological damage in psoriatic arthritisAnnals Of The Rheumatic Diseases, 2006
- Etanercept treatment of psoriatic arthritis: Safety, efficacy, and effect on disease progressionArthritis & Rheumatism, 2004
- A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experienceRheumatology, 2003